BioMed Realty Trust, Inc. (BMR) announced the pricing of public offering of 15 million common shares at $21.40 per share. All of the shares are being sold by the company. The gross proceeds will be approximately $321.0 million.
BioMed Realty expects to use the proceeds to fund a portion of the purchase price for the pending acquisition of Wexford Science & Technology, to repay a portion of the outstanding indebtedness under unsecured line of credit, and for other general corporate and working capital purposes.
The offering is expected to close on or about April 2, 2013.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.